ro 24-7429
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 2, 1999 (NCT00000760)
Timeline
Indications
Mechanism of action
tat antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ro 24-7429
- ro 24-7429
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00000760 | Phase 1 | Nov 2, 1999 | National Institute of Allergy and Infectious Diseases (NIAID), Roche |
| NCT00002314 | Phase 2 | Nov 2, 1999 | Roche |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Roche | For profit | 2 | 1 | 2 | 1999 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 1999 |
2 organizations
Page 1 / 1